# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 6B


The holder of the authorisation shall inform the licensing authority before making a material alteration to the premises or plant used at the POC (IMP) control site, or to the operations for which they are used.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/7/paragraph/6B (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-7/paragraph-6B
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.